Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Kendall Donaldson, ESCRS 2019 – Cataract surgery: looking to the future

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 23rd 2019

Kendall Donaldson (Bascom Palmer Eye Institute) discusses the current limitations and future landscape of cataract surgery at ESCRS 2019.

Questions:
1. What are the limitations of cataract surgery? (0:04)
2. What is on the horizon for presbyopia correction in upcoming years? (0:41)
3. What is the most exciting change in intraocular lens (IOL) calculations and methods for post-operative adjustment? (1:34)
4. Where do you see cataract surgery 10 years from now? (2:34)

Support: No funding was received in the production of this video.
Disclosures: Kendall Donaldson discloses the following financial interests: Alcon, Johnson and Johnson, Allergan, Biotissue, Kala Pharmaceuticals, Eyevance, Omeros, SUN

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup